Teva Announces Launch Of A First Generic Version Of Revlimid
By, Admin1 min read
Share
Teva Pharmaceuticals, A U.S. Affiliate Of Teva Pharmaceutical Industries Ltd. (Nyse And Tase: Teva), Announced Today The Launch Of A First Generic Version Of Revlimid
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
